Back to LOOMIS SAYLES & CO L P LOOMIS SAYLES & CO L P

VRTXVRTX
Showing 8 of 27 quarters

Position history for LOOMIS SAYLES & CO L PLOOMIS SAYLES & CO L P's holdings in VERTEX PHARMACEUTICALS INC

LOOMIS SAYLES & CO L P holds 3.9M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $1.9B as of 2026-Q2. The position was decreased (-2.1% shares). VRTX represents 2.4% of LOOMIS SAYLES & CO L P's portfolio.

Current Value

$1.9B

Current Shares

3.9M

Total Value Change

+$520.7M

Total Shares Change

+852,739

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.9M
-2.1%
$1.9B2.4%$496.73
0
2026-Q1
Decreased
4M
-0.7%
$1.8B2.4%$474.27
0
2025-Q4
Decreased
4M
-2.1%
$1.8B2.2%$453.74
0
2025-Q3
Increased
4.1M
+8.1%
$1.6B1.9%$395.31
54
2025-Q2
Increased
3.8M
+1.7%
$1.7B2.1%$441.30
56
2025-Q1
Decreased
3.7M
-0.7%
$1.8B2.6%$492.69
0
2024-Q4
Increased
3.8M
+23.0%
$1.5B1.9%$399.35
61
2024-Q3
Decreased
3.1M
-2.4%
$1.4B1.9%$462.88
0

Other major holders of VRTX: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used